MENDES S.A. Report issue

For profit Phase 4
Founded: Lugano Switzerland (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2016
NCT02908776
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now